EPOE3K

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Endocrine & Reproductive Research

EPO

Anemia and red blood cell production

EPO specifications and reference prices. Select a specification to add it to your cart.

3000iu *10vials

Reference priceUS$73

For laboratory research only. Not for human or veterinary use.

COA 检测报告 / Reports

Compare all specifications & reference prices
SKUSpecification / packReference price (USD)
E3K3000iu *10vialsUS$73

Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.

RESEARCH FOCUS

Main Uses & FAQs

This page organizes directly related data on anemia and erythropoiesis of EPO. First, look at the research questions and findings, then check the population or species, study formulations, and scope of interpretation.

Main TopicsAnemia · Erythropoiesis
USAGE REFERENCE

EPO · Usage reference (for research purposes)

The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.

🧪Reconstitution

Suggested Diluent
Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
Diluent Volume
Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
Handling Notes
Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.

💾Storage

Unreconstituted Lyophilized Powder
Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
After Reconstitution
Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
Transport
For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.

📏Dosage Reference (Research)

Purpose / SettingCommon Reference
ExplanationErythropoiesis research

🔁Cycle

According to research protocol.

View the Complete Usage Guide Library →

Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.

Research SummaryKey Findings

What research findings exist regarding EPO in anemia and erythropoiesis?

36,000 IU versus 40,000 IU rhEPO efficacy met non-inferiority criteria. Another study reported: long-term Hb effects similar for subcutaneous and intravenous routes, subcutaneous requiring less dose.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
3 Main ReferencesSorted by First Publication Date ↓
Human Study2026REF. 01

What is the significance of comparing study doses in cancer-related anemia?

Research Findings

36,000 IU versus 40,000 IU rhEPO efficacy met non-inferiority criteria.[1] ↗

Study Design

Human multi-center open-label randomized; cancer-related anemia

Scope & Limitations

Dose comparison supports clinical medication optimization, cannot be extended to healthy individuals for enhancing exercise performance.

View the Article Title and Full Citation+

[Comparison of the efficacy and safety of 36 000 IU vs. 40 000 IU recombinant human erythropoietin for the treatment of cancer-related anemia: a multicenter, open-label, randomized controlled trial].

Jia YF, Xia J, Liu XM, Li ZH, Man L, Zhou CY, Cui XJ, Chen MB, Wang YB, Wang S, Sun T.

Chinese Journal of Oncology · Volume/Issue Year 2026
First published 2026-04-01 · PMID 42086522
DOI 10.3760/cma.j.cn112152-20250619-00280

Human Study2026REF. 02

How do EPO delivery pathways for hemodialysis patients compare?

Research Findings

Long-term Hb effects via subcutaneous and intravenous routes are similar, subcutaneous is more dose-saving.[2] ↗

Study Design

Human hemodialysis anemia; administration route observational comparison

Scope & Limitations

Specific plateau region hemodialysis population, non-randomized efficacy not confirmed.

View the Article Title and Full Citation+

Comparison the clinical outcomes of intravenous and subcutaneous erythropoietin administration in hemodialysis patients of plateau regions.

Li Y, Yang C, Xu J, Li D, Xu M, Zhou Z.

BMC Nephrology · Volume and Year 2026
First published 2026-03-04 · PMID 41781903
DOI 10.1186/s12882-026-04790-8

Human Study2026REF. 03

What information does EPO provide as an active control for anemia?

Research Findings

EPO active control group shows improvements in hematological parameters, supporting its use as a reference for existing treatments.[3] ↗

Study Design

Randomized open study of human non-dialysis CKD anemia

Scope & Limitations

Main trial assessed non-inferiority of another drug, not a new confirmation of EPO versus placebo.

View the Article Title and Full Citation+

Comparing the Efficacy of Desidustat Versus Erythropoietin in the Management of Anemia in Patients With Dialysis-Naïve Chronic Kidney Disease: A Randomized Open-Label Trial.

Rabha H, Quaiser S, Naeem SS, Rizvi W.

Cureus · Volume and Issue Year 2026
First published 2026-02-15 · PMID 41859634
DOI 10.7759/cureus.103690

i

Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

GO DEEPER

What Questions Do These Studies Address?

Compare study populations, findings and scope.

↗
QUESTIONS, ANSWERED

EPO · Frequently Asked Questions.

What research findings exist regarding EPO in anemia and erythropoiesis?+

36,000 IU versus 40,000 IU rhEPO efficacy met non-inferiority criteria. Another study reported: long-term Hb effects similar for subcutaneous and intravenous routes, subcutaneous requiring less dose.[1] ↗ [2] ↗

Can anemia research on EPO be used to promote exercise performance in healthy individuals?+

: Not allowed. The selected data come from patients with cancer-related anemia or chronic kidney disease, observing hemoglobin and treatment-related endpoints, and do not support use for exercise in healthy individuals.[1] ↗ [2] ↗ [3] ↗

EPO—these conclusions apply to which study populations?+

Human multi-center open-label randomized; cancer-related anemia; human hemodialysis anemia; administration route observational comparison; human non-dialysis CKD anemia randomized open-label study. Dose comparison supports clinical medication optimization, cannot be extended to healthy people to enhance exercise performance.[1] ↗ [2] ↗ [3] ↗

VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL

Research peptides. Shop by product.

Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.

Ventro Peptides & Biotech Logo
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT

01 / CATALOG

Browse products

7 products Product names, specifications, and prices follow the current quotation
SemaglutideSM10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Semaglutide

10mg/vial x 10vials

US$90.91
TirzepatideTR20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Tirzepatide

20mg/vial x 10vials

US$160.61
RetatrutideRT10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Retatrutide

10mg/vial x 10vials

US$109.09
BPC157BC10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Repair & Recovery Research

BPC157

10mg/vial x 10vials

US$133.33
MOTS-CMS20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Longevity & Mitochondrial Research

MOTS-C

20mg/vial x 10vials

US$257.58
LiraglutideLR10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Liraglutide

10mg*10vials

US$164.71
IGF-lr3IG1COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

IGF-lr3

1mg/vial x 10vials

US$505.88

03 / ABOUT VENTRO

Reliable peptide supply, built for long-term partnerships.

Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.

  • High-purity peptides
  • Available COA reports
  • COA & quality documentation
  • Flexible small-quantity purchases
  • Reliable global fulfillment
  • Research product retail support

04 / QUALITY SYSTEM

Quality without compromise

Browse the available COA reports by product. Confirm documentation for your order with our team.

Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support

RESEARCH PRODUCT INQUIRY

Submit a product inquiry

Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

Contact Ventro

Choose a channel to contact the Ventro team directly.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

WhatsApp